Grade My Investments

Abbott Laboratories (ABT) Stock Grade

ABT · Healthcare

B+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$218.9B
P/E Ratio
33.6
Revenue Growth (YoY)
+5.7%
Net Margin
14.7%
Return on Equity
12.5%
Dividend Yield
1.9%

About Abbott Laboratories's fundamentals

Abbott Laboratories is a large-cap healthcare company with a market capitalization of $218.9 billion that generated 5.7% year-over-year revenue growth. The company maintains a net margin of 14.7%, indicating it converts roughly 15 cents of each revenue dollar into profit, and generates a 12.5% return on equity for shareholders. Trading at a P/E ratio of 33.6, the valuation reflects market expectations for future earnings, while the company returns 1.9% annually to shareholders through dividends.

Track ABT free — no credit card required. Live grade + monthly AI report →